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treatment in fetal tachyarrhythmia by Doppler measurement of
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Germany
1 Introduction
A fetal cardiac arrthythmia may cause uninter-
pretable or even misleading fetal heart rate
(FHR) tracings with unreliable signs of fetal
distress [1]. Therefore evaluation of such artifacts
and the haemodynamic relevance of a fetal ar-
rhythmia by alternative methods [9] is necessary
for management and therapy. Doppler measure-
ment of fetal blood flow has been reported to be
useful for hemodynamic assessment of fetal car-
diac arrythmias [9,10], for detection of imminent
heart failure prior to fetal hydrops and for mon-
itoring of therpaeutic effects of therapy [11].
2 Material and methods
External indirect FHR-monitoring during preg-
nancy and internal direct FHR-monitoring from
the fetal scalp during labor and delivery was
performed with a comerical fetal monitoring sys-
tem with autocorrelation technique (HP 8040
Cardiotocograph, Hewlett-Packard, FRG). For
the recording of a tachycardic FHR, Hewlett-
Packard (Böblingen, FRG) supplied an espe-
cially constructed HP 8041A Cardiotocograph
prototype.
FHR records from both systems were checked
by cw (continuous wave)-Doppler blood flow
measurements in umbilical artery (Doptek Spec-
trum Analyser 9000 with built-in 4 MHz cw-
Doppler, Foptek Ltd, GB).
Blood flow in the fetal descending aorta was
measured with combined real-time and pulsed
Doppler ultrasound (Kretz Combison 320-5:
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5 MHz Sector Ultrasound Scanner with built in
2.2 MHz pulsed Doppler, Duplex system,
KretzTechnik, Austria); with real-time display of
"full" spectral Doppler sonogram (pulse repeti-
tion frequency PRF: 6.25 MHz, wall motion
filter WMF: 125 Hz; adjustments fixed by M. G.)
and off-line estimate of mean velocity (intensity-
weighted spectral and temporal average). Fetal
size and vessel diameter were measured on frozen
ultrasound image from the same system.
3 Clinical information and results
A 28-year-old healthy woman was referred at 30
weeks of gestation because of fetal tachycardia-
bradycardia-arrthythmia. Apart from a hydropic
placenta, ultrasound examination showed nor-
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Figure 1. External FHR record in fetal arrhythmia with paroxysmal bigeminal and trigeminal pulse. Check of
the questionable tracings with cw-Doppler blood flow measurement in umbilical artery (pseudobradycardia).
mal fetal and cardiac anatomy, but with arrhyth-
mia in fetal real-time and M-mode echocardio-
graphy [7, 8]. The obtained FHR-record was
irregular, showing alternating periods of severe
bradycardia. Checking this questionable tracing
by cw-Doppler assessment of umbilical artery
blood flow revealed periods of bigeminal and
trigeminal pulse with a numerically normal heart
rate (figure 1). Obviously the fetal monitoring
system was triggered by one of two or three
pulsations respectively and thus demonstrated
pseudobradycardia.
During the next four hours, the FHR turned to
regular tachycardia by ascultation, but conven-
tional FHR-monitor concealed fetal tachycradia
and mimicked falsely normal FHR. A second
FHR-monitor prototype, designed especially for
fetal tachycardia, recorded FHR correctly, with
a mean hart rate of 240 bpm as demonstrated
with cw-Doppler (figure 2). Oral transplacental
digitalization was started (beta-acetyldigoxin,
3 χ 0.2 mg/d) [4] to prevent recurrent tachycardia
and worsening of fetal heart failure [7, 11 15].
Transplacental cardioversion was not achieved
definitively, however FHR was basically normal
during treatment.
Between 32 and 34 gestational weeks, the patient
discontinued digitalis intake against medical ad-
vice, and a temporary pericardial effusion, be-
tween 34 and 36 weeks, indicated subsequent
worstening of fetal cardiac failure [2]. Serial
pulsed Doppler measurements of fetal aortic
blood flow [3, 9, 10] were performed at 30, 32,
33, 35 and 36 weeks of gestation. Thus imminent
fetal heart failure was recognized after discontin-
ued medication and before pericardial effusion
occured. Furthermore, improvement of fetal car-
diac performance secondary to restarting the
medication and prior to resalution of pericardial
effusion was recognized also (figure 3).
During spontaneous labor and delivery, at 37
weeks of gestation, fetal arrhythmia with bige-
minal pulse recurred, and again internal FHR
monitoring from the fetal scalp showed pseu-
dobradycardia; however, the FHR recording was
correct when "logic" was switched off (figure 4).
The nonhydropic male infant weighed 4150 g
and demonstrated minimal signs of neonatal dis-
tress (Apgar score 5 and 1 at 1 and 5 min re-
spectively) with delayed onset of respiration and
bradycardia, although the pH of umbilical cord
blood was normal (art: 7.32, ven: 7.39).
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Figure 2. Fetal tachycardia with two-to-one block in
conventional fetal monitor (CTG artifact). Top: Ex-
ternal prototype FHR-monitor (*), showiing a correct
trace. Middle: External convention FHR-monitor with
misleading "normal" tracing, as a result of "halving"
true FHR [5]. Bottom: Check of FHR with cw-Dopp-
ler assessment of umbilical artery blood flow: 240 pbm.
(*) Prototype supplied by Hewlett-Packard, Böblingen,
FRG.
Postpartum echocardiography confirmed nor-
mal heart anatomy and ECG showed pre-exita-
tion with delta-waves [14], but no signs of digi-
talis intoxication. Thus a Wolff-Parkinson-White
syndrome was diagnosed and continuation of
digoxin treatment was indicated [6, 12]. At six
months of life, treatment was stopped and fur-
ther examinations revealed normal development
and normal sinus rhythm (Dept. of Pediatrics,
Div. of Pediatric Cardiology, University Hospi-
tal, Tübingen).
4 Discussion
In fetal monitoring systems, preprocessing of
incoming signals according to certain preset lim-








28 32 36 40
ß-Acetyl - N==l 1=1 Cf
digoxin 3xo.2 mg/d
Pericardial effusion [ - [
Figure3. Blood flow in fetal descending aorta: Re-
cognition of impairment and improvement of fetal
cardiac performance prior to evolution and prior to
resolution of pericardial effusion. This effusion ap-
peared after discontinued digitalis intake. Sponta-
neously delivery after 37 weeds of gestation, 4150 g,
Apgar 5/7/9, pH A: 7.32; V: 7.39.
(Nomogram after ERSKINE RLA and RITCHIE JWK
[3]).
its, such as maximal FHR range or maximal
FHR changes ("logic"), and autocorrelation
technique allow indirect and automatical FHR
detection and recognition, in spite of minimal
maternal or fetal movements. These technical
approaches can obscure FHR monitor and
falsely normal FHR is mimicked [5, 7, 8, 13]. In
this case, pre-excitation with bi- or trigeminal
pulse caused severe tachycardia, but on the fetal
monitor appeared a "normal" heart rate tracing
(figure 2); or during the preceding and intrapar-
tum periods of bi- and trigeminal pulse FHR
was numerically normal, but a severe bradycar-
dia was recorded (figures 1, and 4).
Cw-Doppler assessment of umbilical artery
blood flow was a suitable method to check ques-
tionable FHR recordings quickly. With serial
pulsed Doppler measurements of fetal aortic
blood flow, it was possible, first to recognize
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impairment of fetal cardiac performance after
discontinued digitialis intake and prior to devel-
opment of pericardial effusion — and second, to
recognize cardiac improvement after restarting
medication and prior to resolving the effusion
(figure 3).
New monitoring developments and Doppler
measurement of fetal blood flow may be of help
to verify fetal arrthythmia and to quantify their
hemodynamic implications [9,10]. An immiment
heart failure can be detected before signs of fetal
hydrops occur and the therapeutic effect of med-
ication can be monitored by serial measurements
of fetal blood flow [11].
Figure 4. Pseudobradycardia in fetal bigeminal
pulse. Top: Mimicked bradycardia in conventional
external fetal monitoring. Middle: True fetal arrhyth-
mia in conventional internal fetal monitoring and
"logic off". Bottom: Verification of fetal bigeminal
pulse by Doppler assessment of umbilical artery
blood flow.
Abstract
A fetal cardiac arrhythmia may cause misleading fetal
heart rate tracings with unreliable signs of fetal dis-
tress. Assessment of such artifacts and of the hemo-
dynamic relevance of a fetal arrhythmia by alternative
methods is necessary for management and therapy.
A 28-year-old healthy woman was referred at 30 weeks
of gestation because of fetal tachy-brady-arrhythmia,
but cw-Doppler assessment of umbilical artery blood
flow revealed periods of pseudobradycardia during
bigeminal and trigeminal fetal pulse. FHR turned to
regular tachycardia, and transplacental digitalization
was started. Between 32 and 34 weeks the patient
discontinued her digitalis intake, and a fetal pericardial
effusion indicated subsequent cardiac failure. Serial
pulsed Doppler measurements of fetal aortic blood
flow were performed and imminent heart failure was
recognized after the digitalis was discontinued and
before a pericardial effusion occured. Furthermore,
improvement of fetal cardiac performance secondary
to restarting digitalis and also prior to resolution of
the pericardial effusion. After spontaneous delivery a
Wolff-Parkinson-White syndrome was diagnosed, and
continuation of digoxin treatment was indicated.
Cw-Doppler assessment of umbilical artery blood flow
was a suitable method to evaluate questionable FHR
recordings, and pulsed Doppler allowed monitoring of
the therapeutic effect of transplacental digitalization
by serial measurements of fetal aortic blood flow.
Keywords: Bigeminal pulse, CTG artifacts, Doppler ultrasound, fetal arrhythmia, fetal blood flow, fetal
digitalization, pseudobradycardia, Wolff-Parkinson-White syndrome.
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CTG-Artefakte, Hämodynamik und Digitalisierung bei
fetalen Tachyarrhythmien — dopplersonographische
Überwachung am Beispiel eines Präexzitationssyndroms
Eine fetale cardiale Arrhythmie kann nicht interpre-
tierbare oder irreführende Aufzeichnungen der fetalen
Herzfrequenz (FRF) verursachen. Daher ist die Un-
tersuchung solcher CTG-Artefakte [1] und der hämo-
dynamischen Relevanz einer aktuellen fetalen Arrhyth-
mie durch alternative Methoden [9] im Hinblick auf
Management und Therapie notwendig.
Die externe CTG-Überwachung erfolgte mit einem
herkömmlichen Autokorrelationscardiotokographen
(HP 8040). Die FHF-Aufzeichnungen wurden durch
dopplersonographische Strömungsmessungen in der
Umbilikalarterie überprüft (Doptek Spectrum Analy-
ser 9000 mit eingebautem 4 MHz cw-Doppler). Die
Durchblutung in der absteigenden fetalen Aorta wurde
mit kombinierter Real-Time und Pulsdoppler-Sono-
graphie gemessen (Kretz Combison 320-5, Duplex-
System).
Uns wurde eine 28jährige gesunde Frau in der 30.
Schwangerschaftswoche wegen fetaler Tachy-/Bra-
dyarrhythmien überwiesen. Die FHF-Aufzeichnungen
waren irregulär, alternierend traten Phasen mit schwe-
rer Bradykardie auf. Die zugehörigen Dopplersono-
gramme der Umbilikalarterie zeigten jedoch Perioden
mit Bigeminus und Trigeminus, wobei die Herzfre-
quenz numerisch normal war (Abb. l u. 4). Offensicht-
lich wurden im CTG nur eine von 2 oder 3 Pulsationen
erkannt und es zeigte daher eine Pseudobradykardie.
Während der nächsten Stunden wechselte die FHF zu
einer regelmäßigen Tachykardie mit einer mittleren
Frequenz von 240 spm, und wir begannen mit einer
oralen transplazentaren Digitalisierung [15]. Zwischen
32 und 34 Wochen unterbrach die Patientin die Digi-
taliseinnahme und zwischen 34 und 36 Wochen trat
zeitweilig ein Perikarderguß als Hinweis auf eine ma-
nifeste Herzinsuffizienz auf [2]. Die Durchblutungs-
messungen in der fetalen Aorta ließen eine Verschlech-
terung der Herzleistung nach Absetzen der Medikation
und vor Auftreten des Perikardergusses erkennen. Im
weiteren Verlauf war eine Verbesserung der Herzlei-
stung nach Wiedereinsetzen der Medikation und vor
Rückbildung des Perikardergusses nachweisbar
(Abb. 3).
Nach 37 Schwangerschaftswochen kam es zur Spon-
tangeburt eines Kindes ohne Hydrops. Man diagno-
stizierte ein Wolff-Parkinson-White-Syndrome und
setzte die Digitalisbehandlung fort [6,12].
Die Bearbeitung aufgenommener Signale gemäß ge-
wisser vorgegebener Grenzen wie maximalen Bereich
der FHF und maximale FHF-Änderungen ("Logik")
ermöglicht eine automatische FHF-Anzeige und -Er-
kennung. Jedoch können mit dieser Technik FHF-
Aufzeichnungen bei fetalen Tachyarrhythmien unklar
bleiben [1]. Doppleruntersuchungen der Nabelarterien
erwiesen sich als geeignete Methode, um zweifelhafte
FHF-Aufzeichnungen abzuklären. Mit dem gepulsten
Doppler war es möglich, eine beginnende Herzinsuf-
fizienz vor Auftreten von Hydropszeichen zu erkennen
und den therapeutischen Effekt einer transplazentaren
Digitalisierung durch Verlaufsmessungen der fetalen
Aortendurchblutung nachzuweisen [11].
Schlüsselwörter: Bigeminus, CTG-Artefakte, Dopplersonographie, fetale Arrhythmie, fetale Digitalisierung,
fetaler Blutfluß, Pseudeobradykardie, Wolff-Parkinsln-White-Syndrom.
Resume
Evaluation des artefacts CTG, de Phemodynamique et
du traitement par digoxine dans les tachyarythmies
fetales a l'aide de la mesure Doppler du FLUX sanguin
foetal. A propos d'un cas de syndrome de preexitation
Uarythmie cardiaque foetale peut entrainer des enrigs-
trements du rythme cardiaque foetal (RCF) ininterpre-
tables ou meme trompeurs. C'est la raison pour la-
quelle la mise en evidence de tels artefacts du RCF [1]
et de Phemodynamique seconaires ä une arythmie
foetale en cours par des methodes alternatives [9] est
necessaire pour la prise en charge et la therapeutique.
Le monitorage du RCF par voie externe a ete realise
ä l'aide d'un Systeme du surveillance foetale du
commerce avec une technique d'auto-correlation (car-
diotocographe HP 8040). Les enregistrements du RCF
ont ete completes par des mesures doppler au niveau
de Tartere ombilicale (Doptek spectrum analyser 9000
avec 4MHZ cw Doppler), et de Faorte descendante
par association d'echographie combinee en temps reel
et doppler pulse (Kretz Combison 320-5, Duplex sys-
tem).
Une patiente de 29 ans, en bonne sante a ete adressee
ä 30 semaines de gestation en raison d'une tachy-
brady-arythmie foetale. Le RCF etaie irregulier, avec
alternance de periodes de bradycardies majeures, mais
Pexamen doppler de Fartere ombilicale a mis en evi-
dence des periodes de bigeminisme et de trigeminisme
avec un rythme cardiaque foetal numeriquement nor-
mal (figures 1, 4). A Fevidence le monitorage foetal ä
lui seur ne recommit qu'une des deux ou trois pulsa-
tions respectives et met en evidence une pseudobra-
dycardie.
Au cours des heures suivantes, le RCF evolua vers une
tachycardie reguliere, avec un rythme moyen de 240
bpm, et une digitalisation transplacentaire par voie
orale fut commencee [15]. Entre 32 et 34 semaines, la
patiente interrompit son traitement digitalique et un
epanchement pericardique temporaire, entre 34 et 36
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semaines, fut le temoin d'une defaillance cardiaque
consecutive [2]. On effectua des series de mesure dop-
pler pulse du flux sanguin aortique foetal ce qui permit
de reconnaitre une defaillance des performances car-
diaques foetales apres arret de la therapeutique. En
outre, l'amelioration des performances cardiaques
foetales secondaires au redemarrage de la therapeutique
et avant la disparition de 1'epanchement pericardique
fut mis en evidence (Figure 3).
A 37 semaines de gestation naquit un enfant nonhy-
dropique de fagon spontanee. On fit le daignostic de
syndrome de Wolf-Parkinson White et la poursuite du
traitement digoxique fut indiquee [6,12].
Le pretraitement des signaux d'entree selon certaines
limites preetablies, telles que Fetendue maximale du
CRF et les variations maximales du RCF ("logiques"),
permet la detection automatique du RCF et sä recon-
naissance. Mais cette technique peut masquer Fenre-
gistrement du RCF en cas de tachy-arythmie foetale
[1]. L'etude doppler du flux sanguin dans Fartere om-
bilicale est une methode appropriee pour faire le bilan
d'enregistrement du rythme cardiaque foetal a pro-
bleme. Par doppler pulse il est possible de reconnaitre
une defaillance cardiaque imminente avant Fapparition
des signes d'hydrops foetal, et de surveiller les effets
therapeutiques de la digitalisation transplacentaire par
determination en serie du flux sanguin aortique foetal
[11].
Mots-cles: Artefacts CIG, arythmie foetale, debit sanguin foetal, digitalisation foetale, echographie Doppler,
pseudobradycradie, pulse bigemine, syndrome de Wolf-Parkinson-White.
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